Factory Price High Purity 99.0% Cilengitide raw peptide powder CAS NO.:188968-51-6Research Chemical Appearance: white powder
Purity (HPLC) ≥98.0%
Acetate content≤12.0%
Moisture content≤8.0%
Peptide content ≥ 80.0%
Endotoxin≤50EU/mg
Amino acid composition analysis≤±10%
Packaging and Shipping:
Low temperature, vacuum packaging, accurate to milligrams upon request.
Product Description:
Cilengitide is a cyclic peptide containing the RGD sequence. The peptide is based on the αvβ3 integrin ligand in vivo, which is obtained through comprehensive use of cyclization, spatial screening and methylation scanning, and has high affinity and selectivity for αvβ3 integrin. Tests have shown that the peptide can not only inhibit the growth of melanoma and glioblastoma, but also improve the cure rate of other tumors such as squamous cell tumors of the head and neck when combined with radiation therapy. It has good market prospects and potential. In peptide synthesis, Cilengitide is produced by combining solid-phase peptide synthesis technology with liquid-phase peptide synthesis technology.
Storage method: Freeze-dry at -20°C and store in the dark
Audited Supplier 
){kind=link}